Join
Live feed
·
PRReleasevia Quantisnow
60 Degrees Pharmaceuticals Inc. logo

60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SXTP (60 Degrees Pharmaceuticals Inc.) and more on Quantisnow.